23May/13

European Medicines Agency Validates Gilead's Marketing Application for … – Business Wire (press release)

European Medicines Agency Validates Gilead’s Marketing Application for
Business Wire (press release)
Chronic HCV is a major cause of liver cancer and liver transplantation in Europe and around the world. The current standard of care for HCV involves 24-48 weeks of therapy with RBV and peg-IFN, which has to be injected and is associated with

and more »